Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care
Cosimo Galletti, María Antonietta Barbieri, Francesco Ciodaro, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 630-630
Open Access | Times Cited: 24

Showing 24 citing articles:

Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
Cosimo Galletti, Federico Sireci, Giovanna Stilo, et al.
American Journal of Otolaryngology (2025) Vol. 46, Iss. 1, pp. 104597-104597
Open Access | Times Cited: 2
Real‐World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps
Marisa Dorling, Juan Carlos Hernaiz‐Leonardo, Athenea Pascual, et al.
The Laryngoscope (2024) Vol. 134, Iss. 7, pp. 3054-3059
Open Access | Times Cited: 14
Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature
Marella Reale, Giuseppe Licci, Pietro Orlando, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 10, pp. 5023-5031
Closed Access | Times Cited: 9
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
Cosimo Galletti, Martina Ragusa, Federico Sireci, et al.
American Journal of Otolaryngology (2023) Vol. 45, Iss. 1, pp. 104106-104106
Open Access | Times Cited: 19
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence
Marco Caminati, Claudio Micheletto, Francesca Norelli, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 15-23
Closed Access | Times Cited: 7
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care
Cosimo Galletti, Francesco Ciodaro, María Antonietta Barbieri, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 4, pp. 104329-104329
Closed Access | Times Cited: 6
Adherence to Intranasal Steroids in Chronic Rhinosinusitis with Nasal Polyposis Prior to and during Biologic Therapy: A Neglected Matter
Francesca Norelli, Michele Schiappoli, Gianenrico Senna, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1066-1066
Open Access | Times Cited: 5
Efficacy of dupilumab in real-life settings: a STROBE study
A. Gal, R. Gravier-Dumonceau, M. Pénicaud, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4781-4788
Closed Access | Times Cited: 5
Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab
Giovanna Piazzetta, Nadia Lobello, Emanuela Chiarella, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 12
Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR)
Sven Seys, Sven Schneider, Joost de Kinderen, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 4
At The Interface: Small-Molecule Inhibitors of Soluble Cytokines
Raavi, Angela N. Koehler, Arturo J. Vegas
Chemical Reviews (2025)
Closed Access
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type‐2 CRSwNP Over 48 Months
Pietro Orlando, Giuseppe Licci, Gennaro Illiano, et al.
The Laryngoscope (2025)
Closed Access
The Morphology of Nasal Polyps in Different Age Groups: Histopathological Features
Vincenzo Fiorentino, Maurizio Martini, Cosimo Galletti, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 414-414
Open Access | Times Cited: 3
Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma
Tomoko Tajiri, Motohiko Suzuki, Hirono Nishiyama, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 5, pp. 550-558.e2
Closed Access | Times Cited: 3
Rheumatic adverse events associated with biologic therapy for chronic rhinosinusitis: A systematic review and meta‐analysis
Jenny B. Xiao, Helen Hsiao, Carlos Khalil, et al.
International Forum of Allergy & Rhinology (2024) Vol. 14, Iss. 10, pp. 1618-1633
Open Access | Times Cited: 3
Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS)
Victor Pera, Guy Brusselle, Sebastian Riemann, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Multidimensional Impact of Dupilumab on Chronic Rhinosinusitis with Nasal Polyps: A Complete Health Technology Assessment of Clinical, Economic, and Non-Clinical Domains
Ignazio La Mantia, Giancarlo Ottaviano, Martina Ragusa, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 347-347
Open Access | Times Cited: 1
The Impact of Dupilumab on Work Productivity and Emotional Health in CRSwNP: A Multicentric Study in Northeast Italy
Giancarlo Ottaviano, Giuseppe Roccuzzo, L. Lora, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 468-468
Open Access | Times Cited: 1
Antibody-based therapeutics for chronic rhinosinusitis with nasal polyps
Shama Shishodia, Nora Haloob, Claire Hopkins
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 491-502
Closed Access | Times Cited: 1
Is Dupilumab a chance for patients with moderate to severe atopic dermatitis? Literature review
Paweł Iwańczuk
Journal of Education Health and Sport (2024) Vol. 63, pp. 84-94
Open Access
Biologic Therapies across Nasal Polyp Subtypes
Kody G. Bolk, Sarah K. Wise
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 432-432
Open Access
Comparison of Effectiveness of Conventional Polypectomy with Functional Endoscopic Sinus Surgery
Asad Ullah, Momina Zeb, Wajih Ud Din, et al.
Pakistan Journal of Health Sciences (2024), pp. 248-252
Closed Access
Biologics in Rhinology
Samy Elwany
(2024), pp. 387-400
Closed Access
Page 1

Scroll to top